drugset / Trial / NCT07240974
Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies
Phase 0
Recruiting
6 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, single-arm, open-label, dose-escalation, early-phase 1 study to evaluate the safety, tolerability and preliminary efficacy of ZZSW-01 injection in patients with relapsed/refractory B-cell malignancies.
Timeline
- Start
- 2025-10-28
- Primary completion
- 2028-09-15
- Completion
- 2028-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZZSW-01 | Messenger RNA (mRNA) | — | Intravenous |